Normalization of T cell receptor repertoire diversity in patients with advanced colorectal cancer who responded to chemotherapy

Cancer Science

Volumn 102, Issue 4, 2011, Pages 706-712

  Luo, Wei ^a   Liao, Wang Jun ^a   Huang, Yong Ta ^a   Shi, Min ^a   Zhang, Yuan ^a   Wen, Qian ^a   Zhou, Ming Qian ^a   Ma, Li ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; RECOMBINANT ENDOSTATIN; T LYMPHOCYTE RECEPTOR;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CARDIOTOXICITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; COLORECTAL ADENOCARCINOMA; COLORECTAL CANCER; CONTINUOUS INFUSION; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG FATALITY; FEMALE; HEMATURIA; HUMAN; HYPERTENSION; INTESTINE PERFORATION; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; THROMBOCYTOPENIA; THROMBOEMBOLISM; TUMOR GROWTH;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; ENDOSTATINS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT PROTEINS; REMISSION INDUCTION;

EID: 79952757126     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01868.x     Document Type: Article

References (21)

1. + T cells. Eur J Immunol 2009; 39: 241-53.
2. Miura Y, Thoburn CJ, Bright EC et al. Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD. Blood 2001; 98: 868-76.
3. Long SA, Khalili J, Ashe J, Berenson R, Ferrand C, Bonyhadi M. Standardized analysis for the quantification of Vbeta CDR3 T-cell receptor diversity. J Immunol Methods 2006; 317: 100-13.
4. Morgan SM, Hodges E, Mitchell TJ, Harris S, Whittaker SJ, Smith JL. Molecular analysis of T-cell receptor beta genes in cutaneous T-cell lymphoma reveals Jbeta1 bias. J Invest Dermatol 2006; 126: 1893-9.
5. + T cells in vitro obviates the requirement for in vivo vaccination. Blood 2009; 114: 1776-83.
6. João C, Ogle BM, Geyer S. Immunoglobulin promotes the diversity and the function of T cells. Eur J Immunol 2006; 36: 1718-28.
7. Mackall CL, Fleisher TA, Brown MR et al. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 1994; 84: 2221-8.
8. Sutherland JS, Spyroglou L, Muirhead JL et al. Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade. Clin Cancer Res 2008; 14: 1138-49.
9. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332: 143-9.
10. Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-16.
11. National Cancer Institute. Common terminology criteria for adverse events (CTCAE) v3.0. [Cited 9 Aug 2006.] Available from URL: .
12. Luo W, Ma L, Wen Q, Wang N, Zhou MQ, Wang XN. Analysis of the interindividual conservation of T-cell receptor alpha- and beta-chain variable regions gene in the peripheral blood of patients with systemic lupus erythematosus. Clin Exp Immunol 2008; 154: 316-24.
13. Lu J, Basu A, Melenhorst JJ, Young NS, Brown KE. Analysis of T-cell repertoire in hepatitis-associated aplastic anemia. Blood 2004; 103: 4588-93.
14. Takami A, Sugimori C, Feng X et al. Expansion and activation of minor histocompatibility antigen HY-specific T cells associated with graft-versus-leukemia response. Bone Marrow Transplant 2004; 34: 703-9.
15. Luo W, Liao WJ, Ma L et al. Dynamic monitoring the TCR CDR3 spectratypes in patients with metastatic CRC treated with a combination of bevacizumab, irinotecan, fluorouracil, and leucovorin. Cancer Immunol Immunother 2010; 59: 247-56.
16. Mercader M, Bodner BK, Moser MT et al. T-cell infiltration of the prostate induced by androgen withdrawalin patients with prostate cancer. Proc Natl Acad Sci U S A 2001; 98: 14565-70.
17. Waldner M, Schimanski CC, Neurath MF. Colon cancer and the immune system: the role of tumor invading T cells. World J Gastroenterol 2006; 12: 7233-8.
18. Yager EJ, Ahmed M, Lanzer K, Randall TD, Woodland DL, Blackman MA. Age-associated decline in T-cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med 2008; 205: 711-23.
19. Vallejo AN. Age-dependent alterations of the T-cell repertoire and functional diversity of T cells of the aged. Immunol Res 2006; 36: 221-8.
20. Goldrath AW, Bevan MJ. Selecting and maintaining a diverse T-cell repertoire. Nature 1999; 402: 255-62.
21. Naylor K, Li G, Vallejo AN et al. The influence of age on T-cell generation and TCR diversity. J Immunol 2005; 174: 7446-52.